Allisartan isoproxil
A prodrug used in the treatment of hypertension
{{Drugbox
| verifiedfields = changed
| verifiedrevid = 477002282
| IUPAC_name = (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-((2-butyl-4-chloro-5-(hydroxymethyl)-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-imidazol-1-yl)methyl)benzoate
| image = Allisartan_isoproxil.svg
| image2 = Losartan_carboxylic_acid.svg
}}
Allisartan isoproxil is a prodrug used in the management of hypertension. It belongs to the class of medications known as angiotensin II receptor antagonists, which are commonly referred to as ARBs (Angiotensin Receptor Blockers). This medication is specifically designed to lower blood pressure by blocking the action of angiotensin II, a hormone that causes blood vessels to constrict.
Mechanism of Action
Allisartan isoproxil is a prodrug, meaning it is converted into its active form in the body. Upon administration, it is metabolized into its active form, which is similar to losartan carboxylic acid. This active form selectively blocks the binding of angiotensin II to the angiotensin II receptor type 1 (AT1 receptor) on the surface of vascular smooth muscle cells. By inhibiting this interaction, allisartan isoproxil causes vasodilation, leading to a reduction in blood pressure.
Pharmacokinetics
After oral administration, allisartan isoproxil is rapidly absorbed and converted into its active form. The bioavailability of the active metabolite is influenced by factors such as food intake and individual metabolic differences. The drug is primarily excreted via the kidneys, and its half-life allows for once-daily dosing, which can improve patient compliance.
Clinical Use
Allisartan isoproxil is indicated for the treatment of hypertension in adults. It may be used alone or in combination with other antihypertensive agents. The goal of therapy is to reduce the risk of cardiovascular events such as stroke and myocardial infarction by maintaining blood pressure within a target range.
Side Effects
Common side effects of allisartan isoproxil include dizziness, headache, and fatigue. These are generally mild and tend to resolve with continued use. Serious side effects are rare but may include hyperkalemia, renal impairment, and allergic reactions. Patients are advised to report any unusual symptoms to their healthcare provider.
Contraindications
Allisartan isoproxil is contraindicated in patients with known hypersensitivity to the drug or any of its components. It should not be used during pregnancy due to the risk of fetal harm. Caution is advised in patients with renal or hepatic impairment.
Related Pages
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian